Profitelligence Profitelligence · Filing Ledger Open CAH research →

Form 8-K · Current Report · Filed 2025-01-14

Cardinal Health Updates Fiscal Year 2025 Non-GAAP EPS Expectations

Cardinal Health, Inc. updated its fiscal year 2025 non-GAAP diluted earnings per share (EPS) expectations to be toward the high end of the previously provided range of $7.75 to $7.90, driven by strength in the Pharmaceutical and Specialty Solutions segment. The company will present at the JP Morgan 43rd Annual Healthcare Conference on January 14, 2025, and provide further details on its fiscal year 2025 results on its second quarter earnings call on January 30, 2025.

Filer
Cardinal Health Inc. CAH · NYSE
Filed
Accession
0000721371-25-000003
CIK
0000721371
Signal
Low impactHealthcare

Items reported

Item 7.01

Regulation FD Disclosure

Regulation FD Disclosure

Market reaction

Close before filing

$120.86

Next session

+3.2%

Since filing

+90.3%

Latest close

$230.03

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from CAH reporting the same item, with the next session's move:

About Cardinal Health Inc.

Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.

Exchange NYSE Industry Medical Distribution Company website ↗

Never miss another CAH filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts